Facile and Efficient One‐Pot Protocol for Synthesis of 5‐Phenyl‐1,4‐benzodiazepine‐2‐one Derivatives

References

• Sternbach , L. H. 1971 . 1,4‐Benzodiazepines: Chemistry and some aspects of the structure activity relationship . Angew. Chem. Int. Ed. , 10 : 34 – 40 .
   PubMed Web of Science ®Google Scholar
• Walsh , D. A. 1980 . The synthesis of 2‐aminobenzophenones . Synthesis , 9 : 677 – 688 .
   Google Scholar
• Evans , B. E. , Rittle , K. E. , Bock , M. G. , DiPardo , R. M. , Freidinger , R. M. , Whitter , W. L. , Lundell , G. F. , Veber , D. F. , Anderson , P. S. , Chang , R. S. L. , Lotti , V. J. , Cerino , D. J. , Chen , T. B. , Kling , P. G. , Kunkel , K. A. , Springer , J. P. and Hirshfield , J. 1988 . Methods for drug discovery—Development of point, selective, orally effective cholecystokinin antagonist . J. Med. Chem. , 31 : 2235 – 2246 .
   PubMed Web of Science ®Google Scholar
• Patchett , A. A. and Nargund , R. P. 2000 . Privileged structures—An update . Annu. Rep. Med. Chem. , 35 : 289 – 298 .
   Web of Science ®Google Scholar
• Sternbach , L. H. 1979 . Benzodiazepine story . J. Med. Chem. , 22 : 1 – 7 .
   PubMed Web of Science ®Google Scholar
• Herrero , S. , Garcýa‐López , M. T. and Herranz , R. 2003 . Expedient one‐pot synthesis of novel chiral 2‐substituted 5‐phenyl‐1,4‐benzodiazepine scaffolds from amino acid–derived amino nitriles . J. Org. Chem. , 68 : 4582 – 4585 .
   PubMedGoogle Scholar
• Hanley , D. F. and Pozo , M. 2000 . Treatment of satus epilepticus with midazolam in the critical care setting . Int. J. Clin. Pract. , 54 : 30 – 35 .
   PubMedGoogle Scholar
• Hsu , M. C. , Schutt , A. D. , Holly , M. , Slice , L. W. , Sherman , M. I. , Richman , D. D. , Potash , M. J. and Volsky , D. J. 1991 . Inhibition of HIV replication in acute and chronic infections in vitro by a TAT antagonist . Science , 254 : 1799 – 1802 .
   PubMed Web of Science ®Google Scholar
• Selnick , H. G. , Liverton , N. J. , Baldwin , J. J. , Butcher , J. W. , Claremon , D. A. , Elliott , J. M. , Freidinger , R. M. , King , S. A. , Libby , B. E. , McIntyre , C. J. , Pribush , D. A. , Remy , D. C. , Smith , G. R. , Tebben , A. J. , Jurkiewicz , N. K. , Lynch , J. J. , Salata , J. J. , Sanguinetti , M. C. , Siegl , P. K. S. , Slaughter , D. E. and Vyas , K. 1997 . Class III antiarrhythmic activity in vivo by selective blockade of the slowly activating cardiac delayed rectifier potassium current I Ks by (R)‐2‐(2,4‐trifluoromethyl)‐N‐[2‐oxo‐5phenyl‐1‐(2,2,2‐trifluoroethyl)‐2,3‐dihydro‐1H‐benzo[e][1,4]diazepin‐3‐yl]acetamide . J. Med. Chem. , 40 : 3865 – 3868 .
   PubMed Web of Science ®Google Scholar
• James , G. L. , Goldstein , J. L. , Brown , M. S. , Rawson , T. E. , Somers , T. C. , McDowell , R. S. , Crowley , C. W. , Lucas , B. K. , Levinson , A. D. and Marsters , J. C. 1993 . Benzodiazepine peptidomimetics—Potent inhibitors of ras farnesylation in animal cells . Science , 260 : 1937 – 1942 .
   PubMed Web of Science ®Google Scholar
• Liskamp , R. M. J. 1994 . A new application of modified peptides and peptidomimetics—Potential anticancer agents . Angew. Chem., Int. Ed. Engl. , 33 : 305 – 307 .
   Google Scholar
• Wyatt , P. G. , Allen , M. J. , Chilcott , J. , Hickin , G. , Miller , N. D. and Woollard , P. M. 2001 . Structure–activity relationship investigations of a potent and selective benzodiazepine oxytoxin antagonist . Bioorg. Med. Chem. Lett. , 11 : 1301 – 1305 .
   PubMed Web of Science ®Google Scholar
• Dziadulewicz , E. K. , Brown , M. C. , Dunstan , A. R. , Lee , W. , Said , N. B. and Garratt , P. J. 1999 . The design of non‐peptide human bradykinin B‐12 receptor antagonists employing the benzodiazepine peptidomimetic scaffold . Bioorg. Med. Chem. Lett. , 9 : 463 – 468 .
   PubMedGoogle Scholar
• Anzini , M. , Canullo , L. , Braile , C. , Cappelli , A. , Gallelli , A. , Vomero , S. , Menziani , M. C. , Benedetti , P. G. D. , Rizzo , M. , Collina , S. , Azzolina , O. , Sbacchi , M. , Ghelardini , C. and Galeotti , N. 2003 . Synthesis, biological evaluation, and receptor docking simulations of 2‐[(acylamino)ethyl]‐1,4‐benzodiazepines as opioid receptor agonists endowed with antinociceptive and antiamnesic activity . J. Med. Chem. , 46 : 3853 – 3864 .
   PubMedGoogle Scholar
• Buck , I. M. , Black , J. W. , Cooke , T. , Dunstone , D. J. , Gaffen , J. D. , Griffin , E. P. , Harper , E. A. , Hull , R. A. D. , Kalindjian , S. B. , Lilley , E. J. , Linney , I. D. , Low , C. M. R. , McDonald , I. M. , Pether , M. J. , Roberts , S. P. , Shankley , N. P. , Shaxted , M. E. , Steel , K. I. M. , Sykes , D. A. , Tozer , M. J. , Watt , G. F. , Walker , M. K. , Wright , L. and Wright , P. T. 2005 . Optimization of the in vitro and in vivo properties of a novel series of 2,4,5‐trisubstituted imidazoles as potent cholecystokinin‐2 (CCK2) antagonists . J. Med. Chem. , 48 : 6803 – 6812 .
   PubMed Web of Science ®Google Scholar
• Semple , G. , Ryder , H. , Rooker , D. P. , Batt , A. R. , Kendrick , D. A. , Szelke , M. , Ohta , M. , Satoh , M. , Nishiha , A. , Akuzawa , S. and Miyata , K. 1997 . (3R)‐N‐(1‐(tert‐Butylcarbonylmethyl)‐2,3‐dihydro‐2‐oxo‐5‐(2‐pyridyl)‐1H‐1,4‐benzodiazepin‐3‐yl)‐N′‐(3‐(methylamino)phenyl)urea (YF476): A potent and orally active gastrin/CCK‐B antagonist . J. Med. Chem. , 40 : 331 – 341 .
   PubMed Web of Science ®Google Scholar
• Micale , N. , Vairagoundar , R. , Yakovlev , A. G. and Kozikowski , A. P. 2004 . Design and synthesis of a potent and selective peptidomimetic inhibitor of caspase‐3 . J. Med. Chem. , 47 : 6455 – 6458 .
   PubMedGoogle Scholar
• Sternbach , L. H. , Fryer , R. I. , Metlesics , W. , Reeder , E. , Sach , G. , Saucy , G. and Stempel , A. 1962 . Quinazolines and 1,4‐benzodiazepines, VI: Halo‐, methyl‐, and methoxy‐substituted 1,3‐dihydro‐5‐phenyl‐2H‐1,4‐benzodiazepin‐2‐ones . J. Org. Chem. , 27 : 3788 – 3796 .
   Web of Science ®Google Scholar
• Bolli , M. H. , Marfurt , J. , Grisostomi , C. , Boss , C. , Binlcert , C. , Hess , P. , Treiber , E. , Thorin , A. , Morrison , K. , Buchmann , S. , Bur , D. , Ramuz , H. , Clozel , M. , Fischli , W. and Weller , T. 2004 . Novel benzo[1,4]diazepin‐2‐one derivatives as endothelin receptor antagonists . J. Med. Chem. , 47 : 2776 – 2795 .
   PubMed Web of Science ®Google Scholar